OPKO Health Inc. (OPK)
NASDAQ: OPK
· Real-Time Price · USD
1.34
-0.04 (-2.90%)
At close: May 01, 2025, 3:59 PM
1.31
-2.24%
After-hours: May 01, 2025, 06:13 PM EDT
-2.90% (1D)
| Bid | 1.28 |
| Market Cap | 899.88M |
| Revenue (ttm) | 713.14M |
| Net Income (ttm) | -53.22M |
| EPS (ttm) | -0.08 |
| PE Ratio (ttm) | -16.75 |
| Forward PE | -6.02 |
| Analyst | Buy |
| Ask | 1.35 |
| Volume | 4,086,622 |
| Avg. Volume (20D) | 5,098,468 |
| Open | 1.30 |
| Previous Close | 1.38 |
| Day's Range | 1.24 - 1.38 |
| 52-Week Range | 1.15 - 2.04 |
| Beta | 1.79 |
About OPK
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, geneti...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Nov 2, 1995
Employees 2,997
Stock Exchange NASDAQ
Ticker Symbol OPK
Website https://www.opko.com
Analyst Forecast
According to 4 analyst ratings, the average rating for OPK stock is "Buy." The 12-month stock price forecast is $3, which is an increase of 123.88% from the latest price.
Stock ForecastsEarnings Surprise
OPKO Health has released their quartely earnings
on Apr 30, 2025:
3 months ago
+4.14%
Merck & Compnay and OPKO Health shares are trading...
Unlock content with
Pro Subscription
8 months ago
+11.72%
OPKO Health shares are trading higher after the company reported better-than-expected Q2 EPS results.
